checkAd

    DGAP-News  436  0 Kommentare Symrise AG: Executive Board contract of Heinz-Jürgen Bertram extended ahead of schedule until 2022

    DGAP-News: Symrise AG / Key word(s): Change of Personnel/Contract
    Symrise AG: Executive Board contract of Heinz-Jürgen Bertram extended ahead
    of schedule until 2022

    07.12.2016 / 08:00
    The issuer is solely responsible for the content of this announcement.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Symrise AG!
    Short
    109,66€
    Basispreis
    0,71
    Ask
    × 14,83
    Hebel
    Long
    96,81€
    Basispreis
    0,71
    Ask
    × 14,41
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    ---------------------------------------------------------------------------

    - Supervisory Board reaffirms Dr. Heinz-Jürgen Bertram as CEO for a
    further five-year term
    - The Group continues with profitable growth course
    - Strategic focus remains on fast-growing market segments, portfolio
    diversification and access to natural ingredients



    The Supervisory Board of Symrise AG has again renewed the contract of CEO
    Dr. Heinz-Jürgen Bertram ahead of schedule for a further five-year term
    until 2022. Under his leadership, through the focused streamlining of the
    portfolio and by identifying new market segments, Symrise has substantially
    expanded its leading position and tapped into market segments beyond the
    traditional flavors and fragrances business. The reaffirmation of Dr.
    Heinz-Jürgen Bertram as CEO ensures leadership continuity and creates the
    foundation for further profitable growth.

    The Chairman of the Supervisory Board, Dr. Thomas Rabe, said: "We've been
    working with Dr. Heinz-Jürgen Bertram very successfully and in a spirit of
    trust for many years. We are therefore pleased to reaffirm his appointment
    as CEO for a further five years before his contract is up for renewal. Dr.
    Bertram has been part of the Executive Board for more than ten years and
    has worked with Symrise for nearly three decades. He has accelerated the
    pace of the Company's international development and diversification.
    Symrise has an excellent reputation among its customers and in the capital
    market. With the early renewal of Dr. Bertram's contract, we are ensuring
    the Group's continued successful development."

    In recent years, Symrise AG has established new business areas and
    increased its competitiveness through strategic acquisitions, in particular
    with regard to functional product solutions in the fields of nutrition and
    personal care. Moreover, the Company has increased its access to
    sustainable and renewable key raw materials for the production of
    fragrances and flavors. Symrise has been cooperating, for instance, with
    vanilla farmers in Madagascar for many years.

    Dr. Heinz-Jürgen Bertram (58), who has a doctorate in chemistry, has
    performed in various management functions at the Bayer Group, the Haarmann
    & Reimer Group and Symrise since 1985. Since 2003, he has held several
    senior positions with Symrise, and was appointed to the Executive Board in
    2006. Since August 2009, he heads the Company's business activities as CEO.
    Seite 1 von 2


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Symrise AG: Executive Board contract of Heinz-Jürgen Bertram extended ahead of schedule until 2022 DGAP-News: Symrise AG / Key word(s): Change of Personnel/Contract Symrise AG: Executive Board contract of Heinz-Jürgen Bertram extended ahead of schedule until 2022 07.12.2016 / 08:00 The issuer is solely responsible for the content of this …

    Schreibe Deinen Kommentar

    Disclaimer